Gamble Jones Investment Counsel’s Alaunos Therapeutics TCRT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $39.6K | Hold |
407
| – | – | ﹤0.01% | 202 |
|
|
2022
Q3 | $105K | Hold |
407
| – | – | 0.01% | 211 |
|
|
2022
Q2 | $76K | Hold |
407
| – | – | 0.01% | 203 |
|
|
2022
Q1 | $40K | Hold |
407
| – | – | ﹤0.01% | 209 |
|
|
2021
Q4 | $66K | Buy |
407
+200
| +97% | +$32.4K | ﹤0.01% | 214 |
|
|
2021
Q3 | $56K | Hold |
207
| – | – | ﹤0.01% | 213 |
|
|
2021
Q2 | $82K | Hold |
207
| – | – | 0.01% | 217 |
|
|
2021
Q1 | $112K | Hold |
207
| – | – | 0.01% | 212 |
|
|
2020
Q4 | $78K | Hold |
207
| – | – | 0.01% | 207 |
|
|
2020
Q3 | $78K | Hold |
207
| – | – | 0.01% | 203 |
|
|
2020
Q2 | $102K | Buy |
207
+7
| +4% | +$3.45K | 0.01% | 197 |
|
|
2020
Q1 | $74K | Buy |
200
+13
| +7% | +$4.81K | 0.01% | 187 |
|
|
2019
Q4 | $132K | Hold |
187
| – | – | 0.01% | 209 |
|
|
2019
Q3 | $120K | Hold |
187
| – | – | 0.01% | 199 |
|
|
2019
Q2 | $163K | Sell |
187
-13
| -7% | -$11.3K | 0.01% | 207 |
|
|
2019
Q1 | $116K | Hold |
200
| – | – | 0.01% | 206 |
|
|
2018
Q4 | $56K | Buy |
+200
| New | +$56K | 0.01% | 207 |
|